Cystagon (Mylan Pharmaceuticals Inc.)
Welcome to the PulseAid listing for the Cystagon drug offered from Mylan Pharmaceuticals Inc.. This Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Mylan Pharmaceuticals Inc. |
| NON-PROPRIETARY NAME: | cysteamine bitartrate |
| SUBSTANCE NAME: | CYSTEAMINE BITARTRATE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | CAPSULE |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1994-08-15 |
| END MARKETING DATE: | 0000-00-00 |
Cystagon HUMAN PRESCRIPTION DRUG Details:
| Item Description | Cystagon from Mylan Pharmaceuticals Inc. |
| LABELER NAME: | Mylan Pharmaceuticals Inc. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 50(mg/1) |
| START MARKETING DATE: | 1994-08-15 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0378-9040_af3df753-5346-4c68-869a-eac79a887e39 |
| PRODUCT NDC: | 0378-9040 |
| APPLICATION NUMBER: | NDA020392 |
Other CYSTEAMINE BITARTRATE Pharmaceutical Manufacturers / Labelers:
